http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017518083-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1055 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-16 |
filingDate | 2015-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2017-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2017518083-A |
titleOfInvention | Methods and compositions for non-covalent ligation in vivo |
abstract | Disclosed is a method for facilitating the interaction of first and second components, the method comprising the use of antibody fragments and epitope tags. The antibody fragment can be bound to the first component, while the epitope tag can be bound to the second component. The antibody fragment may have binding specificity for the epitope tag sufficient to cause an interaction between the antibody fragment and the epitope tag. In one aspect, a method is provided for promoting the interaction of a first component and a second component, the method comprising: a. Providing an antibody fragment conjugated to a first component; and b. Providing an epitope tag bound to a second component, wherein the antibody fragment is sufficient to cause an interaction between the antibody fragment and the epitope tag binding specificity for the epitope tag including. |
priorityDate | 2014-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1353.